Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatment.
Kazuki MaesakaRyotaro SakamoriRyoko YamadaYuki TahataMasahide OshitaHideki HagiwaraMitsuru SakakibaraShinji TamuraNaoki HiramatsuMasami InadaSadaharu IioToshifumi ItoTakayuki YakushijinYoshinori DoiTakahiro KodamaHayato HikitaTomohide TatsumiTetsuo TakeharaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)
Among HCV-positive patients with decompensated cirrhosis, approximately one-fourth received DAA treatment, but more than 40% of the patients lost the opportunity for treatment with DAAs.